Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Bracketing the size of a therapeutic category that could address one-fifth of the world's adult population is no small task, but therein lies opportunity
The Current State of GLP-1 Drugs 2023 research from IQVIA has shown that demand for GLP-1 drugs has accelerated since early 2020, corresponding to the launches of Ozempic, Wegovy and Mounjaro variations
Wegovy vs mounjaro Wegovy (semaglutide) is approved for managing long-term weight in adults and teens with obesity or being overweight
Important Risk Information Material Risks: Semaglutide is associated with a risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on animal studies
Interventions should be balanced, sustainable, and even enjoyable
Retrieved from Teva Investor Relations
